Lion Point Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,400	Closed	-$909K	–	42
2025 Q3	$909K	Sell	23,400 -22,500	-49%	-$731K	5.16%	6
2025 Q2	$1.27M	Hold	45,900	–	–	8.62%	3
2025 Q1	$1.02M	Hold	45,900	–	–	6.5%	5
2024 Q4	$908K	Sell	45,900 -15,500	-25%	-$354K	4.75%	8
2024 Q3	$1.53M	Sell	61,400 -43,291	-41%	-$1.05M	6.16%	8
2024 Q2	$1.95M	Sell	104,691 -26,000	-20%	-$487K	6.12%	8
2024 Q1	$2.58M	Hold	130,691	–	–	4.93%	7
2023 Q4	$2.29M	Hold	130,691	–	–	2.05%	9
2023 Q3	$2.27M	Hold	130,691	–	–	2.08%	9
2023 Q2	$1.84M	Buy	130,691 +17,151	+15%	+$230K	1.37%	11
2023 Q1	$1.22M	Sell	113,540 -232,960	-67%	-$3.07M	0.67%	19
2022 Q4	$3.69M	Sell	346,500 -133,500	-28%	-$1.94M	1.98%	18
2022 Q3	$5.14M	Hold	480,000	–	–	2.08%	22
2022 Q2	$5.14M	Hold	480,000	–	–	1.81%	26
2022 Q1	$4.77M	Buy	480,000 +425,000	+773%	+$4.5M	1.61%	21
2021 Q4	$647K	Sell	55,000 -440,748	-89%	-$5.42M	0.21%	28
2021 Q3	$5.65M	Hold	495,748	–	–	1.5%	21
2021 Q2	$6.91M	Hold	495,748	–	–	1.64%	18
2021 Q1	$9.18M	Hold	495,748	–	–	2.24%	14
2020 Q4	$8.76M	Hold	495,748	–	–	1.81%	14
2020 Q3	$7.59M	Hold	495,748	–	–	1.7%	15
2020 Q2	$12.6M	Hold	495,748	–	–	3.16%	13
2020 Q1	$7.67M	Buy	+495,748	New	+$7.76M	2.67%	14